Bioinova

Bioinova, a.s. is a Czech biotechnology company that develops and manufactures modern cell therapy medicinal products and in vitro diagnostic medical devices. Its own stem-cell-based medicines are tested in preclinical and clinical studies. Its diagnostics focus on infections and antimicrobial resistance, including PCR sampling sets that do not require DNA/RNA isolation and rapid tests that distinguish viral from bacterial infections.

Customers include physicians, paediatricians, diagnostic laboratories and distributors, parents and dental practices (dental pulp storage), and pharmaceutical manufacturers and researchers (cell storage and transport solutions). The company also offers services such as tissue collection and validated transport, GMP sterility and environmental monitoring, contract development of advanced therapy medicinal products for clinical trials, and regulatory and quality consulting. The website does not disclose pricing or revenue.

Bioinova was founded in 2008 as a spin-off of the Institute of Experimental Medicine of the Czech Academy of Sciences and is headquartered in Prague. The website lists funded projects from the Technology Agency of the Czech Republic, the Ministry of Industry and Trade and Norway Grants, with runs in 2021–2027, and states that it holds manufacturing and tissue establishment authorisations and ISO 9001 and ISO 13485 audits. At the time of the crawl, the careers page listed no open positions.

Product: Cell therapy medicinal products, in vitro diagnostic kits for infections, dental pulp storage, cell storage solutions, and GMP and contract development services.